John W Smither

ARQT

John W Smither serves as director at Arcutis Biotherapeutics, Inc. (ARQT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$137.6K

Net Position

Net Seller

$137.6K

Companies Traded

GNLX, ARQT

Active Period

Mar 2021 – Jul 2026

4 total trades

Most Recent

Sell GNLX

Jul 2, 2026 · $34.9K

John W Smither's Insider Trading at Arcutis Biotherapeutics, Inc. (ARQT)

Buys

0 · $0.00

Sells

2 · $84.0K

Total Shares Bought

Total Shares Sold

2,523

ARQT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 10, 2021	Sell	1,750	$32.90	$57.6K	0
Mar 1, 2021	Sell	773	$34.20	$26.4K	0

John W Smither's Insider Trading at Genelux Corporation (GNLX)

Buys

0 · $0.00

Sells

2 · $53.6K

Total Shares Bought

Total Shares Sold

12,900

GNLX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 2, 2026	Sell	12,000	$2.91	$34.9K	91,403
Sep 14, 2023	Sell	900	$20.78	$18.7K	6,920

Related Insiders

LIN SUE-JEAN

Director

ARQTSell · Jun 17, 2026

Howard G. Welgus

Director

ARQTSell · Jun 17, 2026

Smalling Ralph

officer: Head of Regulatory

GNLXSell · Jun 4, 2026

John Thomas

Director

GNLXSell · Jun 2, 2026

Patrick Burnett

See Remarks

ARQTSell · May 13, 2026

Latha Vairavan

SVP Chief Financial Officer

ARQTSell · May 13, 2026

Thomas Zindrick

officer: President and CEO

GNLXSell · May 12, 2026

Yong Yu

SVP, Clinical Development

GNLXSell · May 12, 2026

Explore More Insider Trading Data

ARQT Insider Trading Activity

View all insider trades at Arcutis Biotherapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity